Home › Funds › Spruce Street Capital LP › ACHV

Spruce Street Capital LP position in ACHV

ACHIEVE LIFE SCIENCE INC · Health Care

Spruce Street Capital LP reported holding 736,637 shares of ACHV (ACHIEVE LIFE SCIENCE INC) in its Q3 2026 13F filing — a position valued at US$6.0M, representing 0.95% of its reported portfolio and ranking #26 among its reported holdings. Spruce Street Capital LP has disclosed ACHV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)736.64K sh
Reported value held$5.96M
Portfolio Weight0.95%
First reportedQ2 2026
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Spruce Street Capital LP's ACHV position evolved

Spruce Street Capital LP first disclosed a stake in ACHV in Q2 2026 at 736,637 shares (US$4.8M). The position peaked in Q3 2026 at 736,637 shares, worth US$6.0M. Across 2 filings, Spruce Street Capital LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 736,637 shares valued at US$6.0M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 736.64K $4.81M New
Q3 2026 736.64K $5.96M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ACHV and 13F data

ACHV (ACHIEVE LIFE SCIENCE INC) is a Health Care company. 67 other funds we track also report a position in ACHV — the largest reported positions include Frazier Life Sciences Management, L.P. (US$49.7M), TPG GP A, LLC (US$44.9M), venBio Partners LLC (US$38.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ACHV

All ACHV fund holders →

FAQ

How long has Spruce Street Capital LP held ACHV?

Spruce Street Capital LP has disclosed ACHV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Spruce Street Capital LP's current position in ACHV?

As of Q3 2026, Spruce Street Capital LP holds 736.64K shares of ACHV (ACHIEVE LIFE SCIENCE INC), valued at $5.96M, representing 0.95% of its reported portfolio and ranking #26.

Has Spruce Street Capital LP been buying or selling ACHV?

In the latest 13F filing (Q3 2026), Spruce Street Capital LP held unchanged its position in ACHV. The position peaked in Q3 2026 at 736.64K shares.

Which other funds hold ACHV?

Other major institutional holders of ACHV include Frazier Life Sciences Management, L.P., TPG GP A, LLC, venBio Partners LLC, among 67 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.